Literature DB >> 35029764

The essential anti-angiogenic strategies in cartilage engineering and osteoarthritic cartilage repair.

Song Chen1, Yixuan Amy Pei2,3, Ming Pei4,5.   

Abstract

In the cartilage matrix, complex interactions occur between angiogenic and anti-angiogenic components, growth factors, and environmental stressors to maintain a proper cartilage phenotype that allows for effective load bearing and force distribution. However, as seen in both degenerative disease and tissue engineering, cartilage can lose its vascular resistance. This vascularization then leads to matrix breakdown, chondrocyte apoptosis, and ossification. Research has shown that articular cartilage inflammation leads to compromised joint function and decreased clinical potential for regeneration. Unfortunately, few articles comprehensively summarize what we have learned from previous investigations. In this review, we summarize our current understanding of the factors that stabilize chondrocytes to prevent terminal differentiation and applications of these factors to rescue the cartilage phenotype during cartilage engineering and osteoarthritis treatment. Inhibiting vascularization will allow for enhanced phenotypic stability so that we are able to develop more stable implants for cartilage repair and regeneration.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Anti-angiogenic factor; Articular cartilage; Inflammation; Phenotype stability; Tissue engineering; Vascularization

Mesh:

Substances:

Year:  2022        PMID: 35029764     DOI: 10.1007/s00018-021-04105-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  234 in total

Review 1.  A pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturation.

Authors:  Elena Kozhemyakina; Andrew B Lassar; Elazar Zelzer
Journal:  Development       Date:  2015-03-01       Impact factor: 6.868

Review 2.  Chondrocyte hypertrophy in skeletal development, growth, and disease.

Authors:  Margaret Man-Ger Sun; Frank Beier
Journal:  Birth Defects Res C Embryo Today       Date:  2014-03

Review 3.  Antiangiogenic and anticancer molecules in cartilage.

Authors:  Debabrata Patra; Linda J Sandell
Journal:  Expert Rev Mol Med       Date:  2012-01-19       Impact factor: 5.600

Review 4.  Angiogenesis: a therapeutic target in arthritis.

Authors:  D A Walsh; L Haywood
Journal:  Curr Opin Investig Drugs       Date:  2001-08

Review 5.  Articular cartilage biology.

Authors:  Michael Ulrich-Vinther; Michael D Maloney; Edward M Schwarz; Randy Rosier; Regis J O'Keefe
Journal:  J Am Acad Orthop Surg       Date:  2003 Nov-Dec       Impact factor: 3.020

Review 6.  New aspects of the pathogenesis of osteoarthritis: the role of fibroblast-like chondrocytes in late stages of the disease.

Authors:  F Tesche; N Miosge
Journal:  Histol Histopathol       Date:  2005-01       Impact factor: 2.303

Review 7.  Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk.

Authors:  Steven R Goldring; Mary B Goldring
Journal:  Nat Rev Rheumatol       Date:  2016-09-22       Impact factor: 20.543

8.  Increased failure rate of autologous chondrocyte implantation after previous treatment with marrow stimulation techniques.

Authors:  Tom Minas; Andreas H Gomoll; Ralf Rosenberger; Ronald O Royce; Tim Bryant
Journal:  Am J Sports Med       Date:  2009-03-04       Impact factor: 6.202

Review 9.  Phenotypic instability of chondrocytes in osteoarthritis: on a path to hypertrophy.

Authors:  Purva Singh; Kenneth B Marcu; Mary B Goldring; Miguel Otero
Journal:  Ann N Y Acad Sci       Date:  2018-07-15       Impact factor: 5.691

10.  Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis.

Authors:  Sunita Suri; Sarah E Gill; Sally Massena de Camin; Deborah Wilson; Daniel F McWilliams; David A Walsh
Journal:  Ann Rheum Dis       Date:  2007-04-19       Impact factor: 19.103

View more
  1 in total

1.  miR-210-3p protects against osteoarthritis through inhibiting subchondral angiogenesis by targeting the expression of TGFBR1 and ID4.

Authors:  Han Tang; Wenrun Zhu; Lu Cao; Jin Zhang; Juncheng Li; Duan Ma; Changan Guo
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.